1
…………………GENERALIDADES FARMACOCINETICA …………………………….. FARMACODIMANIA TOXICOLOGIA Gilda Erosa-rejón, M. Peña-rodríguez , ,Olov sterner, IsolatIon of kaempferol-3-rutInosIde from the leaf extract of Sideroxylon foetidissimum suBsp. Rev. Latinoamer. Quím. 38/1 (2010). Gerd Bobe, Paul S. Albert, Leah B. Sansbury, et al. Interleukin-6 as a Potential Indicator for Prevention of High Risk Adenoma Recurrence by Dietary Flavonols in the Polyp Prevention Trial, Cancer Prev Res (Phila). 2010 June ; 3(6): 764–775. doi:10.1158/1940-6207.CAPR-09-0161. E Park, K Sapkota, S Kim, et al. Kaempferol acts through mitogen-activated protein kinases and protein model of neuroinflammation in BV2 microglial cells, British Journal of Pharmacology (2011) 164 1008–1025. L Thors, M Belghiti, CJ Fowler, Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids, British Journal of Pharmacology (2008) 155 244–252.

KAEMPFEROL CARTEL AMEFAR 2016

Embed Size (px)

Citation preview

Page 1: KAEMPFEROL CARTEL AMEFAR 2016

……………………GENERALIDADES FARMACOCINETICA

……………………………….. FARMACODIMANIA TOXICOLOGIA

Gilda Erosa-rejón, M. Peña-rodríguez, ,Olov sterner, IsolatIon of kaempferol-3-rutInosIde from the leaf extract of Sideroxylon foetidissimum

suBsp. Rev. Latinoamer. Quím. 38/1 (2010).

Gerd Bobe, Paul S. Albert, Leah B. Sansbury, et al. Interleukin-6 as a Potential Indicator for Prevention of High Risk Adenoma Recurrence by

Dietary Flavonols in the Polyp Prevention Trial, Cancer Prev Res (Phila). 2010 June ; 3(6): 764–775. doi:10.1158/1940-6207.CAPR-09-0161.

E Park, K Sapkota, S Kim, et al. Kaempferol acts through mitogen-activated protein kinases and protein

model of neuroinflammation in BV2 microglial cells, British Journal of Pharmacology (2011) 164 1008–1025.

L Thors, M Belghiti, CJ Fowler, Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids, British Journal

of Pharmacology (2008) 155 244–252.